A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
使用重组改良痘苗病毒安卡拉株 (MVA-hTyr) 对 II 期黑色素瘤患者进行酪氨酸酶 I 期疫苗接种研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-004-0616-7
Meyer Ralf G, Britten Cedrik M, Siepmann Ulrike, Petzold Barbara, Sagban Tolga A, Lehr Hans A, Weigle Bernd, Schmitz Marc, Mateo Luis, Schmidt Burkhard, Bernhard Helga, Jakob Thilo, Hein Rüdiger, Schuler Gerold, Schuler-Thurner Beatrice, Wagner Stephan N, Drexler Ingo, Sutter Gerd, Arndtz Nathaly, Chaplin Paul, Metz Jost, Enk Alexander, Huber Christoph, Wölfel Thomas
